Does This Pipeline Promise Tomorrow's Blockbuster Sales?
Motley Fool
Pfizer's future looks strong with its robust pipeline that boasts 74 total drugs in development, and at least in late-stage candidates, Merck looks strong as well, with another 23 therapies in phase 2 development. However, it's the quality, not the ...
read all at
http://www.fool.com/investing/general/2013/06/12/does-this-pipeline-promise-tomorrows-blockbuster-s.aspx
No comments:
Post a Comment